Non-genomic effect of glucocorticoids on cardiovascular system
- 23 September 2012
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 464 (6) , 549-559
Abstract
Glucocorticoids (GCs) are essential steroid hormones for homeostasis, development, metabolism, and cognition and possess anti-inflammatory and immunosuppressive actions. Since glucocorticoid receptor II (GR) is nearly ubiquitous, chronic activation or depletion of GCs leads to dysfunction of diverse organs, including the heart and blood vessels, resulting predominantly from changes in gene expression. Most studies, therefore, have focused on the genomic effects of GC to understand its related pathophysiological manifestations. The nongenomic effects of GCs clearly differ from well-known genomic effects, with the former responding within several minutes without the need for protein synthesis. There is increasing evidence that the nongenomic actions of GCs influence various physiological functions. To develop a GC-mediated therapeutic target for the treatment of cardiovascular disease, understanding the genomic and nongenomic effects of GC on the cardiovascular system is needed. This article reviews our current understanding of the underlying mechanisms of GCs on cardiovascular diseases and stress, as well as how nongenomic GC signaling contributes to these conditions. We suggest that manipulation of GC action based on both GC and GR metabolism, mitochondrial impact, and the action of serum- and glucocorticoid-dependent kinase 1 may provide new information with which to treat cardiovascular diseases.Keywords
This publication has 133 references indexed in Scilit:
- Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid ReceptorsJournal of Biological Chemistry, 2012
- Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Glucocorticosteroids: current and future directionsBritish Journal of Pharmacology, 2010
- Foetal hypoxia increases cardiac AT2R expression and subsequent vulnerability to adult ischaemic injuryCardiovascular Research, 2010
- Corticosteroid-binding globulin: The clinical significance of altered levels and heritable mutationsMolecular and Cellular Endocrinology, 2010
- The role of phosphorylated glucocorticoid receptor in mitochondrial functions and apoptotic signalling in brain tissue of stressed Wistar ratsThe International Journal of Biochemistry & Cell Biology, 2009
- Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthoodNeurotoxicology and Teratology, 2009
- Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescueJournal of Bioenergetics and Biomembranes, 2009
- Dynamic regulation of mitochondrial function by glucocorticoidsProceedings of the National Academy of Sciences, 2009
- Protein phosphatase 5The International Journal of Biochemistry & Cell Biology, 2008